Wijngaard Peter's Form 4 filing
Hepion Pharmaceuticals, Inc. (HEPA) · filed Nov 28, 2023
- Accession no.
- 0001104659-23-121427
- Filed
- Nov 28, 2023
- Trade date
- Nov 24-27, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $15.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wijngaard PeterCIK 0001778501 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2023 | Common Stock | PPurchaseAcquired | +2,500 | $3.09 | +$7,725 | 7,001 | Direct | |
| Nov 27, 2023 | Common Stock | PPurchaseAcquired | +2,500 | $3.05 | +$7,625 | 9,501 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.